[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522353":3},{"organization":4,"armGroups":7,"interventions":16,"overallOfficials":22,"centralContacts":26,"locations":35,"responsibleParty":54,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":75,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Indiana University","OTHER",[8,13],{"label":9,"type":10,"description":10,"interventionNames":11},"Black patients with advanced cancer",null,[12],"Behavioral: Social Determinants of Health and toxicity questionnaires",{"label":14,"type":10,"description":10,"interventionNames":15},"Non Black patients with advanced cancer",[12],[17],{"type":18,"name":19,"description":20,"armGroupLabels":21,"otherNames":10},"BEHAVIORAL","Social Determinants of Health and toxicity questionnaires","Collect detailed clinical, and social data from patients to identify significant contributors of disparate survival and toxicity outcomes.",[9,14],[23],{"name":24,"affiliation":5,"role":25},"Bryan P Schneider, MD","PRINCIPAL_INVESTIGATOR",[27,32],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},"Maria McQuade, BA","CONTACT","(317) 278-5238","mcquadem@iu.edu",{"name":24,"role":29,"phone":33,"phoneExt":10,"email":34},"317-948-3855","bpschnei@iu.edu",[36],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center","RECRUITING","Indianapolis","Indiana","46202","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-86.15804,39.76838,{"lat":48,"lon":47},[51,52],{"name":28,"role":29,"phone":30,"phoneExt":10,"email":31},{"name":53,"role":25,"phone":10,"phoneExt":10,"email":10},"Bryan Schneider, MD",{"type":25,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Bryan Schneider","Assistant Professor of Clinical Medicine","100522353","evaluating-disparities-in-precision-oncology-100522353",false,"NCT06081517","Evaluating Disparities in Precision Oncology","Evaluating Disparities in Precision Oncology: An Observational Trial in the Context of a Real-World Academic Practice Model","EDPO","Inclusion Criteria:\n\n1. Ability to provide written informed consent and HIPAA authorization\n2. Patients must be ≥ 18 years old at the time of consent\n3. Patients who have or are planning to undergo molecular testing as part of their routine cancer care\n\nExclusion Criteria:\n\nN\u002FA","ALL","18 Years",{"count":68,"type":69},10600,"ESTIMATED","OBSERVATIONAL","This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.",[73,74],"Metastatic Cancer","Advanced Cancer",[76,77],"Precision Medicine","Disparities","2026-06-12",{"date":80,"type":81},"2026-06-16","ACTUAL",{"date":83,"type":81},"2024-01-26",{"date":85,"type":69},"2028-12",{"name":5,"class":6},1]